Literature DB >> 25925345

Live birth rates in the different combinations of the Bologna criteria poor ovarian responders: a validation study.

Antonio La Marca1, Valentina Grisendi, Simone Giulini, Giovanna Sighinolfi, Alessandra Tirelli, Cindy Argento, Claudia Re, Daniela Tagliasacchi, Tiziana Marsella, Sesh Kamal Sunkara.   

Abstract

PURPOSE: to compare the baseline characteristics and chance of live birth in the different categories of poor responders identified by the combinations of the Bologna criteria and establish whether these groups comprise a homogenous population.
METHODS: database containing clinical and laboratory information on IVF treatment cycles carried out at the Mother-Infant Department of the University Hospital of Modena between year 2007 and 2011 was analysed. This data was collected prospectively and recorded in the registered database of the fertility centre. Eight hundred and thirty women fulfilled the inclusion/ exclusion criteria of the study and 210 women fulfilled the Bologna criteria definition for poor ovarian response (POR). Five categories of poor responders were identified by different combinations of the Bologna criteria.
RESULTS: There were no significant differences in female age, AFC, AMH, cycle cancellation rate and number of retrieved oocytes between the five groups. The live birth rate ranged between 5.5 and 7.4 % and was not statistically different in the five different categories of women defined as poor responders according to the Bologna criteria.
CONCLUSION: The study demonstrates that the different groups of poor responders based on the Bologna criteria have similar IVF outcomes. This information validates the Bologna criteria definition as women having a uniform poor prognosis and also demonstrates that the Bologna criteria poor responders in the various subgroups represent a homogenous population with similar pre-clinical and clinical outcomes.

Entities:  

Mesh:

Year:  2015        PMID: 25925345      PMCID: PMC4491085          DOI: 10.1007/s10815-015-0476-4

Source DB:  PubMed          Journal:  J Assist Reprod Genet        ISSN: 1058-0468            Impact factor:   3.412


  44 in total

Review 1.  A rational approach to the management of low responders in in-vitro fertilization.

Authors:  V Karande; N Gleicher
Journal:  Hum Reprod       Date:  1999-07       Impact factor: 6.918

2.  Optimum number of oocytes for a successful first IVF treatment cycle.

Authors:  M H van der Gaast; M J C Eijkemans; J B van der Net; E J de Boer; C W Burger; F E van Leeuwen; B C J M Fauser; N S Macklon
Journal:  Reprod Biomed Online       Date:  2006-10       Impact factor: 3.828

3.  High live birth rate in the subsequent IVF cycle after first-cycle poor response among women with mean age 35 and normal FSH.

Authors:  Lobke M Moolenaar; Seema Mohiuddin; Moira Munro Davie; Margaret A Merrilees; Frank J M Broekmans; Ben Willem J Mol; Neil P Johnson
Journal:  Reprod Biomed Online       Date:  2013-07-18       Impact factor: 3.828

4.  Cessation of gonadotropin-releasing hormone agonist therapy combined with high-dose gonadotropin stimulation yields favorable pregnancy results in low responders.

Authors:  B M Faber; J Mayer; B Cox; D Jones; J P Toner; S Oehninger; S J Muasher
Journal:  Fertil Steril       Date:  1998-05       Impact factor: 7.329

5.  The clinical analysis of poor ovarian response in in-vitro-fertilization embryo-transfer among Chinese couples.

Authors:  X M Zhen; J Qiao; R Li; L N Wang; P Liu
Journal:  J Assist Reprod Genet       Date:  2008-01-18       Impact factor: 3.412

6.  Determining an anti-Mullerian hormone cutoff level to predict clinical pregnancy following in vitro fertilization in women with severely diminished ovarian reserve.

Authors:  Zaher Merhi; Athena Zapantis; Dara S Berger; Sangita K Jindal
Journal:  J Assist Reprod Genet       Date:  2013-08-21       Impact factor: 3.412

7.  Absence of effect of adjuvant growth hormone therapy on follicular responses to exogenous gonadotropins in women: normal and poor responders.

Authors:  A G Shaker; R Fleming; M E Jamieson; R W Yates; J R Coutts
Journal:  Fertil Steril       Date:  1992-11       Impact factor: 7.329

Review 8.  Clinical management of low ovarian response to stimulation for IVF: a systematic review.

Authors:  B C Tarlatzis; L Zepiridis; G Grimbizis; J Bontis
Journal:  Hum Reprod Update       Date:  2003 Jan-Feb       Impact factor: 15.610

Review 9.  Anti-Mullerian hormone (AMH) as a predictive marker in assisted reproductive technology (ART).

Authors:  A La Marca; G Sighinolfi; D Radi; C Argento; E Baraldi; A Carducci Artenisio; G Stabile; A Volpe
Journal:  Hum Reprod Update       Date:  2009-09-30       Impact factor: 15.610

10.  The rate of high ovarian response in women identified at risk by a high serum AMH level is influenced by the type of gonadotropin.

Authors:  Joan-Carles Arce; Bjarke M Klein; Antonio La Marca
Journal:  Gynecol Endocrinol       Date:  2014-02-27       Impact factor: 2.260

View more
  22 in total

Review 1.  Efficacy of the delayed start antagonist protocol for controlled ovarian stimulation in Bologna poor ovarian responders: a systematic review and meta-analysis.

Authors:  Shuang Yang; Nenghui Liu; Yanping Li; Lei Zhang; Rongya Yue
Journal:  Arch Gynecol Obstet       Date:  2020-11-24       Impact factor: 2.344

2.  Anti-Müllerian hormone and Inhibin B after stem cell transplant in childhood: a comparison of myeloablative, reduced intensity and treosulfan-based chemotherapy regimens.

Authors:  Alison Leiper; Maite Houwing; E Graham Davies; Kanchan Rao; Siobhan Burns; Emma Morris; Joop Laven; Anne-Lotte van der Kooi; Marry van den Heuvel Eibrink; Stephen Nussey
Journal:  Bone Marrow Transplant       Date:  2020-03-30       Impact factor: 5.483

3.  Delayed Start Protocol with Gonadotropin-releasing Hormone Antagonist in Poor Responders Undergoing In Vitro Fertilization: A Randomized, Double-blinded, Clinical Trial.

Authors:  Afsoon Zarei; Mohammad Ebrahim Parsanezhad; Maryam Azizi Kutenaei; Bahia Namavar Jahromi; Parastoo Soheil Esfahani; Pardis Bakhshaei
Journal:  Oman Med J       Date:  2018-11

Review 4.  The Bologna criteria for poor ovarian response: a contemporary critical appraisal.

Authors:  Johnny S Younis; Moshe Ben-Ami; Izhar Ben-Shlomo
Journal:  J Ovarian Res       Date:  2015-11-17       Impact factor: 4.234

5.  Efficacy and safety of follitropin alfa/lutropin alfa in ART: a randomized controlled trial in poor ovarian responders.

Authors:  P Humaidan; W Chin; D Rogoff; T D'Hooghe; S Longobardi; J Hubbard; J Schertz
Journal:  Hum Reprod       Date:  2017-03-01       Impact factor: 6.918

6.  The effect of the pooling method on the live birth rate in poor ovarian responders according to the Bologna criteria.

Authors:  Serdar Çelik; Niyazi Emre Turgut; Dilek Cengiz Çelik; Kübra Boynukalın; Remzi Abalı; Sevim Purisa; Erbil Yağmur; Mustafa Bahçeci
Journal:  Turk J Obstet Gynecol       Date:  2018-03-29

Review 7.  Defining Low Prognosis Patients Undergoing Assisted Reproductive Technology: POSEIDON Criteria-The Why.

Authors:  Sandro C Esteves; Matheus Roque; Giuliano M Bedoschi; Alessandro Conforti; Peter Humaidan; Carlo Alviggi
Journal:  Front Endocrinol (Lausanne)       Date:  2018-08-17       Impact factor: 5.555

8.  Double Stimulation in the Same Ovarian Cycle (DuoStim) to Maximize the Number of Oocytes Retrieved From Poor Prognosis Patients: A Multicenter Experience and SWOT Analysis.

Authors:  Alberto Vaiarelli; Danilo Cimadomo; Elisabetta Trabucco; Roberta Vallefuoco; Laura Buffo; Ludovica Dusi; Fabrizio Fiorini; Nicoletta Barnocchi; Francesco Maria Bulletti; Laura Rienzi; Filippo Maria Ubaldi
Journal:  Front Endocrinol (Lausanne)       Date:  2018-06-14       Impact factor: 5.555

9.  Comparison of Cumulative Live Birth Rates Between GnRH-A and PPOS in Low-Prognosis Patients According to POSEIDON Criteria: A Cohort Study.

Authors:  Shaodi Zhang; Yisha Yin; Qiuyuan Li; Cuilian Zhang
Journal:  Front Endocrinol (Lausanne)       Date:  2021-06-21       Impact factor: 5.555

10.  Oligo/Amenorrhea Is an Independent Risk Factor Associated With Low Ovarian Response.

Authors:  Kai-Lun Hu; Kwanghann Gan; Yue Ying; Junyan Zheng; Ruixue Chen; Jinglei Xue; Yiqing Wu; Yifeng Liu; Yimin Zhu; Lanfeng Xing; Dan Zhang
Journal:  Front Endocrinol (Lausanne)       Date:  2021-06-09       Impact factor: 5.555

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.